Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to assess non-invasive tools' efficacy in predicting portal hypertension-related complications in individuals with advanced chronic liver disease. The main question it aims to answer are: - what are the cut-off values for non-invasive tests (NITs) (including LSM, SSM) that predict the presence and occurrence of hepatic decompensation in individuals with advanced chronic liver disease? Participants will undergo regular study visits involving non-invasive tests (LSM, SSM) and assessments to monitor hepatic decompensation over the study period.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06181409
Study type Observational
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact Amine Benmassaoud, MD
Phone 514-934-1934
Email amine.benmassaoud@mcgill.ca
Status Not yet recruiting
Phase
Start date December 2023
Completion date December 2028

See also
  Status Clinical Trial Phase
Recruiting NCT06434753 - Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease. Phase 3
Terminated NCT02034279 - The INFECIR-2 Albumin Prevention Study Phase 4
Active, not recruiting NCT05663944 - REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. The RESUS Proof of Concept Study Phase 2
Not yet recruiting NCT06449339 - Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease Phase 4
Not yet recruiting NCT05602870 - Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit N/A
Recruiting NCT04615091 - Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery